RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Lotus Pharmaceutical Co Stock

Lotus Pharmaceutical Co Debt 2024

Lotus Pharmaceutical Co Debt

9,813.91 TWD

Ticker

1795.TW

ISIN

TW0001795003

In 2024, Lotus Pharmaceutical Co's total debt was 9,813.91 TWD, a 10.35% change from the 8,893.83 TWD total debt recorded in the previous year.

Lotus Pharmaceutical Co Aktienanalyse

What does Lotus Pharmaceutical Co do?

The Lotus Pharmaceutical Co. Ltd is a leading pharmaceutical conglomerate based in Taiwan. The company was founded in 1964 and has since become one of the most significant manufacturers of pharmaceutical products in Asia. In recent years, Lotus Pharm has undergone a strategic expansion into international markets and is now present in other countries such as Europe and the USA with its innovative products. The company's business model includes the manufacturing and distribution of pharmaceuticals, medical devices, and dietary supplements. The company relies on close collaboration with partners from the science and research sectors to constantly develop innovative products. The core divisions include Cardiovascular, Endocrinology, Gastroenterology, Immunology, Infectious Diseases, Neurology, Oncology, and Respiratory. In the Cardiovascular division, Lotus Pharm offers a range of products for the treatment of cardiovascular diseases. These include medications for lowering blood pressure, lowering cholesterol levels, and preventing blood clots. The Endocrinology division, on the other hand, provides medications for treating hormonal disorders and metabolic diseases. Examples of these are medications for treating diabetes or thyroid diseases. The Gastroenterology division includes products for the treatment of stomach and intestinal diseases, including medications for reflux, stomach problems, or digestive disorders. Immunology deals with medications for treating autoimmune diseases and allergic conditions, while Infectious Diseases offers medications for infectious diseases. Neurology, on the other hand, includes medications for the treatment of neurological diseases such as pain, migraines, epilepsy, or Alzheimer's. Another important area is Oncology, in which Lotus Pharm offers products for the treatment of cancer. In recent years, the company has introduced numerous innovative medications to the market, which can improve survival rates and enhance the quality of life for cancer patients. Lotus Pharm's product range also includes a range of dietary supplements that are intended to provide the body with essential nutrients and contribute to maintaining health and well-being. Lotus Pharm's products are manufactured in modern production facilities that adhere to the highest quality standards. To meet these high standards, the company relies on continuous monitoring of the manufacturing processes and strict quality assurance. Another crucial factor for the success of Lotus Pharm is its close collaboration with partners from the science and research sectors. The company works closely with leading scientists and researchers to continually gain new insights and promote innovation. In recent years, the company has also expanded into the international market and is now represented in Europe and the USA with its products. This demonstrates that Lotus Pharm's products are in high demand outside of Asia and enjoy international recognition. Overall, it can be said that Lotus Pharmaceutical Co. Ltd is a leading company in the pharmaceutical industry. The close collaboration with researchers and partners, the high quality of the products, and the constant innovation make the company a significant player in the industry. Lotus Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Lotus Pharmaceutical Co's Debt Structure

Lotus Pharmaceutical Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Lotus Pharmaceutical Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Lotus Pharmaceutical Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Lotus Pharmaceutical Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Lotus Pharmaceutical Co stock

What is the debt of Lotus Pharmaceutical Co this year?

Lotus Pharmaceutical Co has a debt level of 9,813.91 TWD this year.

What was the debt of Lotus Pharmaceutical Co compared to the previous year?

The debt of Lotus Pharmaceutical Co has increased by 10.35% compared to the previous year increased.

What are the consequences of high debt for investors in Lotus Pharmaceutical Co?

High debt can pose a risk for investors of Lotus Pharmaceutical Co, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Lotus Pharmaceutical Co?

Low debt means that Lotus Pharmaceutical Co has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Lotus Pharmaceutical Co affect the company?

An increase in debt of Lotus Pharmaceutical Co can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Lotus Pharmaceutical Co affect the company?

A reduction in debt of Lotus Pharmaceutical Co can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Lotus Pharmaceutical Co?

Some factors that can influence the debt of Lotus Pharmaceutical Co include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Lotus Pharmaceutical Co so important for investors?

The debts of Lotus Pharmaceutical Co are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Lotus Pharmaceutical Co take to change the debt?

To change the debt, Lotus Pharmaceutical Co can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Lotus Pharmaceutical Co pay?

Over the past 12 months, Lotus Pharmaceutical Co paid a dividend of 3.46 TWD . This corresponds to a dividend yield of about 1.33 %. For the coming 12 months, Lotus Pharmaceutical Co is expected to pay a dividend of 4.11 TWD.

What is the dividend yield of Lotus Pharmaceutical Co?

The current dividend yield of Lotus Pharmaceutical Co is 1.33 %.

When does Lotus Pharmaceutical Co pay dividends?

Lotus Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of August, September, August, September.

How secure is the dividend of Lotus Pharmaceutical Co?

Lotus Pharmaceutical Co paid dividends every year for the past 6 years.

What is the dividend of Lotus Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 4.11 TWD are expected. This corresponds to a dividend yield of 1.58 %.

In which sector is Lotus Pharmaceutical Co located?

Lotus Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Lotus Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Lotus Pharmaceutical Co from 8/30/2024 amounting to 4.647 TWD, you needed to have the stock in your portfolio before the ex-date on 8/5/2024.

When did Lotus Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 8/30/2024.

What was the dividend of Lotus Pharmaceutical Co in the year 2023?

In the year 2023, Lotus Pharmaceutical Co distributed 1.931 TWD as dividends.

In which currency does Lotus Pharmaceutical Co pay out the dividend?

The dividends of Lotus Pharmaceutical Co are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Lotus Pharmaceutical Co

Our stock analysis for Lotus Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lotus Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.